Barasertib-hqpa
WebCompounds of the general formula (I) as described and defined herein, methods for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds and pharmaceutical compositions for the treatment or prevention of diseases, in particular cancer or conditions with dysregulated … WebJan 15, 2024 · Barasertib. CAS No. : 722543-31-9. Biological Activity：Barasertib (AZD1152), a pro-drug of Barasertib-hQPA, is a highly selective Aurora B inhibitor with …
Barasertib-hqpa
Did you know?
WebBarasertib (AZD1152) is a pro-drug that rapidly undergoes phosphatase-mediated cleavage in serum to release barasertib-hQPA, a selective Aurora B kinase inhibitor that has … WebSystemic exposure to barasertib-hQPA, the more active moiety to which barasertib is converted, was observed by 1 and 6 h into the 2-h and continuous infusion ... barasertib …
WebAzd-1152hqpa C26H30FN7O3 CID 16007391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities ... WebPurpose: Barasertib (AZD1152) is a pro-drug that rapidly undergoes phosphatase-mediated cleavage in serum to release barasertib-hQPA, a selective Aurora B kinase inhibitor that …
WebBarasertib-HQPA a Biochemical by MedChemExpress. Barasertib a Biochemical by MedChemExpress. Volasertib a Biochemical by MedChemExpress. Protease Inhibitor Cocktail a Biochemical by MilliporeSigma. Journal Cell Death & Disease Volume 14 Issue 1 Pages 12 Publication Date 10 January ... WebBarasertib-HQPA. AZD2811; INH-34; AZD1152-HQPA. Aurora Kinase Apoptosis Cancer; 巴拉塞替-HQPA Barasertib-HQPA (AZD2811) 是一种高度选择性的极光激酶B抑制剂，在非细胞试验中 IC 50 值为0.37 nM。Barasertib-HQPA (AZD2811) 对可引起癌细胞生长阻滞和 …
WebApr 11, 2024 · Barasertib is a promising ATP-competitive Aurora B inhibitor classified as a pyrazoloquinazoline derivative that has shown potent activity against this target in various assays. Barasertib is also known by the names AZD2811, AZD1152, and AZD1152-HQPA. It was created through the optimization of the ZM447439 inhibitor.
WebJun 16, 2011 · Barasertib-hQPA is a highly selective inhibitor of aurora-B kinase that has shown tumouricidal activity against a range tumour cell lines including those of leukaemic AML origin. Methods Effect of barasertib-hQPA on the pHH3 biomarker and cell viability was measured in a panel of leukaemic cell lines and 37 primary AML samples by flow … tourist attraction map of franceWebBarasertib is a prodrug that rapidly undergoes phospha- tase-mediated cleavage in serum to release barasertib-hQPA, a highly potent and selective inhibitor of Aurora B kinase. … potting boxesWebFeb 23, 2024 · Barasertib is a prodrug of AZD1152-HQPA. Moreover, AZD1152-HQPA is a specific inhibitor of Aurora kinase, with selectivity for Aurora B. Especially, AZD1152 … tourist attraction in western capeWebBarasertib, previously known as AZD1152-hydroxyquinazoline pyrazol anilide (HQPA), is a potent aurora kinase inhibitor, which is resulted from rapid phosphatase-mediated … potting cactus babiesWebBarasertib (AZD1152-HQPA) is a highly selective Aurora B inhibitor with IC50 of 0.37 nM in a cell-free assay, ~3700 fold more selective for Aurora B over Aurora A. Phase 1. Targets … tourist attraction kenosha wiWebBarasertib-HQPA treatment induced defective cell survival, polyploidy, and cell death in LNCaP cell line[3]. Barasertib-HQPA induces a marked anti-propliferative effect … tourist attraction near agraWebAug 29, 2024 · Barasertib (AZD1152-HQPA) Date August 29, 2024 Author dna-pk inhibitor Category Uncategorized. Product Name: Barasertib (AZD1152-HQPA) Description: … potting cactus